BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24169962)

  • 1. Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients.
    Leclerc D; Lévesque N; Cao Y; Deng L; Wu Q; Powell J; Sapienza C; Rozen R
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1171-81. PubMed ID: 24169962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression and methylation in the retinoid/PPARA pathway and of tumor suppressors may modify intestinal tumorigenesis induced by low folate in mice.
    Leclerc D; Cao Y; Deng L; Mikael LG; Wu Q; Rozen R
    Mol Nutr Food Res; 2013 Apr; 57(4):686-97. PubMed ID: 23001810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics reveals differentially expressed proteins in murine preneoplastic intestine in a model of intestinal tumorigenesis induced by low dietary folate and MTHFR deficiency.
    Leclerc D; Dejgaard K; Mazur A; Deng L; Wu Q; Nilsson T; Rozen R
    Proteomics; 2014 Nov; 14(21-22):2558-65. PubMed ID: 25081070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species.
    Darsigny M; Babeu JP; Seidman EG; Gendron FP; Levy E; Carrier J; Perreault N; Boudreau F
    Cancer Res; 2010 Nov; 70(22):9423-33. PubMed ID: 21062980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
    Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
    Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
    Song J; Medline A; Mason JB; Gallinger S; Kim YI
    Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of methylation biomarkers that distinguish normal colon mucosa of cancer patients from normal colon mucosa of patients without cancer.
    Cesaroni M; Powell J; Sapienza C
    Cancer Prev Res (Phila); 2014 Jul; 7(7):717-26. PubMed ID: 24806665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic role of PDK4 in human colon cancer cells.
    Leclerc D; Pham DN; Lévesque N; Truongcao M; Foulkes WD; Sapienza C; Rozen R
    Br J Cancer; 2017 Mar; 116(7):930-936. PubMed ID: 28208156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
    Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dietary folate initiates intestinal tumors in mice, with altered expression of G2-M checkpoint regulators polo-like kinase 1 and cell division cycle 25c.
    Knock E; Deng L; Wu Q; Leclerc D; Wang XL; Rozen R
    Cancer Res; 2006 Nov; 66(21):10349-56. PubMed ID: 17079455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes.
    Martinez C; Bhattacharya S; Freeman T; Churchman M; Ilyas M
    J Pathol; 2005 May; 206(1):100-10. PubMed ID: 15809971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers correlate with colon cancer and risks: a preliminary study.
    Lu S; Chiu YS; Smith AP; Moore D; Lee NM
    Dis Colon Rectum; 2009 Apr; 52(4):715-24. PubMed ID: 19404080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
    Lepourcelet M; Tou L; Cai L; Sawada J; Lazar AJ; Glickman JN; Williamson JA; Everett AD; Redston M; Fox EA; Nakatani Y; Shivdasani RA
    Development; 2005 Jan; 132(2):415-27. PubMed ID: 15604097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling.
    Chevillard-Briet M; Quaranta M; Grézy A; Mattera L; Courilleau C; Philippe M; Mercier P; Corpet D; Lough J; Ueda T; Fukunaga R; Trouche D; Escaffit F
    Hum Mol Genet; 2014 Apr; 23(8):2120-31. PubMed ID: 24287617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
    Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
    Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.